Used primarily in cancer research, this compound is a potent inhibitor of the epidermal growth factor receptor (EGFR), which is often overactive in various types of cancers. By blocking EGFR signaling pathways, it helps in studying the mechanisms of tumor growth and proliferation. It is particularly valuable in preclinical studies for developing targeted therapies that aim to inhibit cancer cell growth without affecting normal cells. Additionally, it is utilized in biochemical assays to understand the role of EGFR in cellular processes and to screen for potential anti-cancer drugs. Its application extends to exploring resistance mechanisms in EGFR-mutated cancers, aiding in the development of more effective treatment strategies.